The 10 Most Read Articles Published in Circulation Research in 2016
Alexei Ilinykh,Malina J. Ivey,Jill T. Kuwabara,Michelle L. D’Antoni,Zhiwei Zhong,Yan Wu,Jing Zhao,Yingchao Wang,Haifeng Cheng,Minjian Kong,Fengjiang Zhang,Jianzhong Sun,Qian Li,Jing Jin,Lihong Chen,Chen Wang,Hongwei Zhan,Qian Yang,Rongrong Wu,Jinyun Zhu,Wei Zhu,Jian’an Wang
2013-01-01
Abstract:Rationale—Proton pump inhibitors (PPIs) are popular drugs for gastroesophageal reflux, which are now available for long-term use without medical supervision. Recent reports suggest that PPI use is associated with cardiovascular, renal, and neurological morbidity. Objective—To study the long-term effect of PPIs on endothelial dysfunction and senescence and investigate the mechanism involved in PPI-induced vascular dysfunction. Methods and Results—Chronic exposure to PPIs impaired endothelial function and accelerated human endothelial senescence by reducing telomere length. Conclusions—Our data may provide a unifying mechanism for the association of PPI use with increased risk of cardiovascular, renal, and neurological morbidity and mortality. From the August 19, 2016 issue: Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status Amy R. Cameron, Vicky L. Morrison, Daniel Levin, Mohapradeep Mohan, Calum Forteath, Craig Beall, Alison D. McNeilly, David J.K. Balfour, Terhi Savinko, Aaron K.F. Wong, Benoit Viollet, Kei Sakamoto, Susanna C. Fagerholm, Marc Foretz, Chim C. Lang, Graham Rena Abstract Rationale—The diabetes mellitus drug metformin is under investigation in cardiovascular disease, but the molecular mechanisms underlying possible benefits are poorly understood. Objective—Here, we have studied anti-inflammatory effects of the drug and their relationship to antihyperglycemic properties. Methods and Results—In primary hepatocytes from healthy animals, metformin and the IKKβ (inhibitor of kappa B kinase) inhibitor BI605906 both inhibited tumor necrosis factor-α–dependent IκB degradation and expression of proinflammatory mediators interleukin-6, interleukin-1β, and CXCL1/2 (C-X-C motif ligand 1/2). Metformin suppressed IKKα/β activation, an effect that could be separated from some metabolic actions, in that BI605906 did not mimic effects of metformin on lipogenic gene expression, glucose production, and AMP-activated protein kinase activation. Equally AMPactivated protein kinase was not required either for mitochondrial suppression of IκB degradation. Consistent with discrete anti-inflammatory actions, in macrophages, metformin specifically blunted secretion of proinflammatory cytokines, without inhibiting M1/M2 differentiation or activation. In a large treatment naive diabetes mellitus population cohort, we observed differences in the systemic inflammation marker, neutrophil to lymphocyte ratio, after incident treatment with either metformin or sulfonylurea monotherapy. Compared with sulfonylurea exposure, metformin reduced the mean log-transformed neutrophil to lymphocyte ratio after 8 to 16 months by 0.09 U (95% confidence interval, 0.02–0.17; P=0.013) and increased the likelihood that neutrophil to lymphocyte ratio would be lower than baseline after 8 to 16 months (odds ratio, 1.83; 95% confidence interval, 1.22–2.75; P=0.00364). Following up these findings in a double-blind placebo controlled trial in nondiabetic heart failure (trial registration: NCT00473876), metformin suppressed plasma cytokines including the agingassociated cytokine CCL11 (C-C motif chemokine ligand 11). Conclusion—We conclude that anti-inflammatory properties of metformin are exerted irrespective of diabetes mellitus status. This may accelerate investigation of drug utility in nondiabetic cardiovascular disease groups. Clinical Trial Registration—Name of the trial registry: TAYSIDE trial (Metformin in Insulin Resistant Left Ventricular [LV] Dysfunction). URL: https://www.clinicaltrials.gov. Unique identifier: NCT00473876. From the September 16, 2016 issue: Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure Hendrik B. Sager, Maarten Hulsmans, Kory J. Lavine, Marina B. Moreira, Timo Heidt, Gabriel Courties, Yuan Sun, Yoshiko Iwamoto, Benoit Tricot, Omar F. Khan, James E. Dahlman, Anna Borodovsky, Kevin Fitzgerald, Daniel G. Anderson, Ralph Weissleder, Peter Libby, Filip K. Swirski, Matthias Nahrendorf Abstract Rationale—Macrophages reside in the healthy myocardium, participate in ischemic heart disease, and modulate myocardial infarction (MI) healing. Their origin and roles in post-MI remodeling of nonischemic remote myocardium, however, remain unclear. Objective—This study investigated the number, origin, phenotype, and function of remote cardiac macrophages residing in the nonischemic myocardium in mice with chronic heart failure after coronary ligation. Methods and Results—Eight weeks post MI, fate mapping and flow cytometry revealed that a 2.9-fold increase in remote macrophages results from both increased local macrophage proliferation and monocyte recruitment. Heart failure produced by extensive MI, through activation of the sympathetic nervous system, expanded medullary and extramedullary hematopoiesis. Circulating Ly6Chigh monocytes rose from 64±5 to 108±9 per microliter of blood (P<0.05). Cardiac monocyte recruitment declined in Ccr2−/− mice, reducing macrophage numbers in the failing myocardium. Mechanical strain of primary murine and human macrophage cultures promoted cell cycle entry, suggesting that the increased wall tension in post-MI heart failure stimulates local macrophage proliferation. Strained cells activated the mitogen-activated protein kinase pathway, whereas specific inhibitors of this pathway reduced macrophage proliferation in strained cell cultures and in the failing myocardium (P<0.05). Steady-state cardiac macrophages, monocyte-derived macrophages, and locally sourced macrophages isolated from failing myocardium expressed different genes in a pattern distinct from the M1/ M2 macrophage polarization paradigm. In vivo silencing of endothelial cell adhesion molecules curbed post-MI monocyte by gest on M arch 4, 2017 http://circhajournals.org/ D ow nladed from 770 Circulation Research March 3, 2017 recruitment to the remote myocardium and preserved ejection fraction (27.4±2.4 versus 19.1±2%; P<0.05). Conclusions—Myocardial failure is influenced by an altered myeloid cell repertoire. From the September 30, 2016 issue: A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart Matthew Ackers-Johnson, Peter Yiqing Li, Andrew P. Holmes, Sian-Marie O’Brien, Davor Pavlovic, Roger S. Foo Abstract Rationale—Cardiovascular disease represents a global pandemic. The advent of and recent advances in mouse genomics, epigenomics, and transgenics offer ever-greater potential for powerful avenues of research. However, progress is often constrained by unique complexities associated with the isolation of viable myocytes from the adult mouse heart. Current protocols rely on retrograde aortic perfusion using specialized Langendorff apparatus, which poses considerable logistical and technical barriers to researchers and demands extensive training investment. Objective—To identify and optimize a convenient, alternative approach, allowing the robust isolation and culture of adult mouse cardiac myocytes using only common surgical and laboratory equipment. Methods and Results—Cardiac myocytes were isolated with yields comparable to those in published Langendorffbased methods, using direct needle perfusion of the LV ex vivo and without requirement for heparin injection. Isolated myocytes can be cultured antibiotic free, with retained organized contractile and mitochondrial morphology, transcriptional signatures, calcium handling, responses to hypoxia, neurohormonal stimulation, and electric pacing, and are amenable to patch clamp and adenoviral gene transfer techniques. Furthermore, the methodology permits concurrent isolation, separation, and coculture of myocyte and nonmyocyte cardiac populations. Conclusions—We present a novel, simplified method, demonstrating concomitant isolation of viable cardiac myocytes and nonmyocytes from the same adult mouse heart. We anticipate that this new approach will expand and accelerate innovative research in the field of cardiac biology.8 From the October 14, 2016 issue: RBM20 Regulates Circular RNA Production From the Titin Gene Mohsin A.F. Khan, Yolan J. Reckman, Simona Aufiero, Maarten M.G. van den Hoogenhof, Ingeborg van der Made, Abdelaziz Beqqali, Dave R. Koolbergen, Torsten B. Rasmussen, Jolanda van der Velden, Esther E. Creemers, Yigal M. Pinto Abstract Rationale—RNA-binding motif protein 20 (RBM20) is essential for normal splicing of many cardiac genes, and loss of RBM20 causes dilated cardiomyopathy. Given its role in splicing, we hypothesized an important role for RBM20 in forming circular RNAs (circRNAs), a novel class of noncoding RNA molecules. Objective—To establish the role of RBM20 in the formation of circRNAs in the heart. Methods and Results—Here, we performed circRNA profiling on ribosomal depleted RNA from human hearts and identified the expression of thousands of circRNAs, with some of them regulated in disease. Interestingly, we identified 80 circRNAs to be expressed from the titin gene, a gene that is known to undergo highly complex alternative splicing. We show that some of these circRNAs are dynamically regulated in dilated cardiomyopathy but not in hypertrophic cardiomyopathy. We generated RBM20-null mice and show that they completely lack these titin circRNAs. In addition, in a cardiac sample from an RBM20 mutation carrier, titin circRNA production was severely altered. Interestingly, the loss of RBM20 caused only a specific subset of titin circRNAs to be lost. These circRNAs originated from the RBM20-regulated I-band region of the titin transcript. Conclusions—We show that RBM20 is crucial for the formation of a subset of circRNAs that originate from the I-band of the titin gene. We propose that RBM20, by excluding specific exons from the pre-mRNA, provides the substrate to form this class of RBM20-dependent circRNAs. From the October 28, 2016 issue: Cardiac Fibroblast GRK2 Deletion Enhances Contractility and Remodeling Following Is